Targeted Therapies in Urothelial Carcinoma

Learn how experts incorporate the newest targeted therapies and antibody–drug conjugates into optimal management of advanced progressive urothelial carcinoma with downloadable slides from a live CCO Webinar.

Share

Program Content

Activities

Immunotherapy in UC
Evolution of Immunotherapy and Maintenance Therapy for Advanced Urothelial Carcinoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 26, 2021

Expires: February 25, 2022

Immunotherapy in UC
New Targeted Therapies and Emerging Data in Urothelial Carcinoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 26, 2021

Expires: February 25, 2022

EP: Targeted Tx in UC
Express Points: New Targeted Therapies and the Evolution of Urothelial Carcinoma Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2021

Expires: March 10, 2022

Activities

Targeted Tx in UC: Video
New Targeted Therapies and the Evolution of Urothelial Carcinoma Care
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2021

Expires: March 24, 2022

Faculty

cover img faculity

Petros Grivas, MD, PhD

Associate Professor
Clinical Director
, Genitourinary Cancers Program
Division of Medical Oncology
Department of Medicine
University of Washington
Associate Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle Cancer Care Alliance
Seattle, Washington

cover img faculity

Cora N. Sternberg, MD

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Immunomedics